There is growing harmonisation between leading regulators across the world and WHO is taking note of the observations made by US FDA on pharma companies everywhere, says Surajit Pal, pharma analyst at Prabhudas Lilladher.
Once this deal is concluded, the company will be renamed as Alembic Mami SPA.
Ranbaxy shares declined a further 2 percent on Wednesday morning after a media report said a prominent hospital in Mumbai had advised doctors to stop using the pharma company's drugs.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.